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Abstract	
	
In	order	to	meet	the	increasing	demand	for	dairy	products	in	China	big	cattle	farms	
have	been	 formed	 throughout	 the	country.	To	control	 the	outbreak	and	 spread	of	
disease	 antibiotics	 are	 readily	 employed,	 and	 detection	 methods	 are	 needed	 to	
ensure	 that	 the	produced	milk	does	not	contain	 levels	of	antibiotics	exceeding	 the	
regulatory	limits.	The	aim	of	this	project	was	to	develop	and	optimize	a	commercially	
utilizable	 microwell-based	 lateral	 flow	 immunoassay	 for	 the	 detection	 of	 the	
antibiotic	 tetracycline	 in	cow	milk.	The	final	conditions	 for	the	developed	test	strip	
included	a	test	 line	with	an	antigen	(TC-BSA)	concentration	of	2µg/µl	and	a	control	
line	 with	 a	 secondary	 antibody	 (goat	 anti-mouse	 IgG)	 concentration	 of	 0.08µg/µl.	
Each	microwell	contained	5µl	of	detection	antibody	(anti-TC)	with	a	concentration	of	
0.12µg/µl	 as	 well	 as	 5µl	 of	 Tris-HCl	 buffer	 with	 pH	 7.5	 and	 5µl	 of	 the	 surfactant	
Tetronic	 1307.	 These	 conditions	 resulted	 in	 an	 assay	 detection	 limit	 of	 30ppb	
tetracycline	and	an	expected	shelf	life	of	at	least	12	months,	with	a	total	assay	time	
of	around	6-7	minutes.	 	
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1.	Introduction		
	
The	 last	 few	decades	have	seen	a	substantial	 increase	 in	the	demand	for	dairies	 in	
China,	and	 this	has	 in	 turn	 shifted	 the	dairy	production	of	 the	country	 from	small-
scale,	 local	 farms	 to	 industrialized	 mega-farms.	 One	 of	 the	 major	 challenges	 that	
such	 a	mega-farm	 faces	 is	 the	maintaining	 of	 animal	welfare	 since	 the	 number	 of	
cattle	residing	in	a	very	restricted	area	can	reach	numbers	up	to	ten	thousand	(Balch	
2014).	 The	 most	 efficient	 way	 to	 control	 and	 prevent	 the	 outbreak	 of	 disease	 is	
through	 treatment	 with	 different	 kinds	 of	 antibiotics,	 many	 of	 which	 are	 readily	
available	without	any	kind	of	prescription	throughout	China	(McLaughlin	2016).	
	
Residues	of	antibiotics	present	in	dairy	products	can	have	negative	effects	on	human	
health	 and	 is	 a	 matter	 of	 food	 safety.	 In	 addition	 to	 this,	 uncontrolled	 and	
irresponsible	 over-usage	 of	 antibiotics	 in	 the	 livestock	 sector	 has	 been	 shown	 to	
increase	 bacterial	 resistance	 against	 these	 drugs	 (Granados-Chinchilla	 et	 al.	 2017).	
This	has	severe	implications	for	the	future	health	prospects	for	people	all	around	the	
globe,	 as	 common	 diseases	 and	 small	 injuries	 might	 lead	 to	 untreatable,	 life-
threatening	 conditions.	 Based	 on	 this	 there	 is	 an	 undeniable	 need	 for	 simple	 yet	
trustworthy	methods	capable	of	detecting	the	levels	of	antibiotics	present	in	milk,	to	
ensure	that	precautionary	regulations	set	by	the	government	are	followed.		
	
1.1	Aim	
	
The	 aim	 of	 this	 project	 was	 to	 develop	 and	 optimize	 a	 commercially	 utilizable	
microwell-based	 lateral	 flow	 immunoassay	 for	 the	 detection	 of	 the	 antibiotic	
tetracycline	 in	 cow	 milk.	 This	 included	 finding	 optimal	 antibody	 and	 antigen	
concentrations,	 pH	 values	 and	 choice	 of	 surfactant	 for	 construction	 of	 a	 highly	
sensitive	yet	easily	assembled	assay.	
	
1.2	Tetracycline		
	
Tetracyclines	 (TCs)	 are	 a	 group	 of	 broad-spectrum	 antibiotics	 that	 are	 commonly	
used	 in	 cases	 of	 veterinary	 medicine.	 Their	 effect	 on	 bacteria	 is	 a	 result	 of	 TCs	
blocking	 the	 ribonucleic	 acid	 aminoacyl	 from	 binding	 to	 the	 ribosome,	 thus	
obstructing	 the	 bacterial	 protein	 synthesis.	 If	 ingested	 with	 food	 TCs	 might,	 in	
addition	 to	 increase	 the	 antibiotic	 resistance	 of	 bacteria,	 also	 cause	 more	 direct	
harm	 in	 the	 body	 such	 as	 allergic	 reactions,	 deformation	 of	 mucus	 tissues	 and	
problems	with	the	gastrointestinal	tract.	The	most	commonly	used	antibiotics	from	
the	 tetracycline	 family	 used	 in	 veterinary	 cases	 are	 tetracycline	 (TC),	
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chlortetracycline	 (CTC)	 and	 oxytetracycline	 (OTC)	 (Taranova	 et	 al.	 2015).	 The	 EU	
requirement	 for	 tetracycline	 in	milk	 is	a	maximum	residue	 limit	 (MRL)	of	100µg/kg	
(100ppb)	 while	 the	 Chinese	 government	 standard	 is	 an	 MRL	 of	 50µg/kg	 (50ppb)	
(Fang	and	Zweigenbaum,	n.d.).		
	
	
	
Figure	1.	Showing	the	molecular	structure	of	tetracycline	(ResearchGate	2017)	
	
1.3	Lateral	flow	immunoassay	
	
Also	 known	 as	 immunochromatographic	 test	 paper	 technology,	 the	 lateral	 flow	
immunoassay	(LFIA)	allows	rapid	detection	of	specific	analytes	in	a	sample	with	the	
help	 of	 immunological	 techniques	 (Shan	 et	 al.	 2014).	 The	 first	 commercially	
successful	 product	 that	 applied	 the	 LFIA	 technology	 was	 the	 Clearview	 home	
pregnancy	test,	which	was	launched	in	1988	by	Unipath.	Since	then	the	use	of	LFIA	
has	spread	to	numerous	other	fields	and	is	today	used	in	for	instance	clinical	trials,	
the	agricultural	sector	and	the	food	industry	(Cytodiagnostics	2017).		
	
The	main	principle	behind	LFIA	is	the	migration	of	a	sample	through	a	test	strip	upon	
which	biological	components	with	binding	capacity	to	the	target	analyte	have	been	
pre-immobilized.	Two	different	assay	formats	are	used	depending	on	the	properties	
of	 the	 analyte;	 the	 sandwich	 assay	 and	 the	 competitive	 assay.	 The	 sandwich	
approach	 is	 suitable	 for	 bigger	 analyte	 molecules	 that	 can	 be	 bound	 to	 two	
antibodies	simultaneously	whereas	the	competitive	approach	is	preferred	when	the	
analyte	 is	 relatively	 small	 and	 only	 capable	 of	 binding	 one	 antibody	 (Shan	 et	 al.	
2014).	For	detection	of	tetracycline	in	cow	milk	the	competitive	version	is	therefore	
best	suited.		
	
One	 of	 the	 main	 strong	 points	 of	 LFIA	 is	 its	 simple	 arrangement	 that	 enables	
detection	 tests	 to	 be	 performed	 directly	 on	 site	 without	 the	 need	 to	 transport	
samples	to	a	laboratory	(Tecnalab	2017).	This,	in	combination	with	uncompromised	
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sensitivity,	low	production	costs	and	quickly	obtained	results,	has	rightfully	brought	
LFI	to	the	frontline	of	immunologic	analytical	methods.		
	
Figure	2	shows	the	overall	principle	for	a	competitive	lateral	flow	immunoassay.	
	
	
	
Figure	2.	Showing	the	principle	behind	competitive	lateral	flow	immunoassay.	A)	Positive	
result.	Since	the	analyte	(TC)	is	present	in	the	sample	it	forms	complexes	together	with	the	
detection	antibody,	and	so	when	the	sample	passes	the	TC	present	on	the	test	line	no	or	
little	detection	antibody	will	be	free	to	bind	causing	the	test	line	to	remain	blank	or	only	
vaguely	colored.	B)	Negative	result.	The	analyte	is	not	present	in	the	sample	leading	to	the	
detection	antibody	binding	 to	 the	TC	present	on	the	 test	 line,	giving	 rise	 to	a	prominent	
red	 line.	 In	both	positive	and	negative	 cases	 the	 secondary	antibody	on	 the	 control	 line	
will	bind	the	detection	antibody	to	ensure	proper	functioning	of	the	test.	 (Adapted	from	
Guide	to	Lateral	Flow	Immunoassays	by	Innova	Biosciences,	2016).	
	
1.3.1	Components	
	
Conventional	LFIA	test	strips	consist	of	a	sample	pad,	a	conjugate	pad,	an	absorbent	
pad	and	a	nitrocellulose	membrane,	all	attached	to	some	sort	of	supporting	material	
for	increased	stability	(Hsieh	et	al.	2017).		
	
The	main	function	of	the	sample	pad	 is	to	absorb	the	sample	added	and	to	further	
distribute	 it	 along	 the	 test	 strip	 in	 a	 controlled	 manner.	 It	 is	 important	 that	 the	
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material	 has	 a	 low	 protein-binding	 ability	 to	 prevent	 any	 loss	 of	 analyte	 (Innova	
Biosciences	2017).		
	
In	 the	 most	 common	 version	 of	 lateral	 flow	 immunoassays	 a	 conjugate	 pad	 is	
situated	right	next	to	the	sample	pad.	The	conjugate	pad	has	the	detection	antibody	
sprayed	and	dried	onto	it,	which	is	released	into	the	liquid	and	starts	reacting	with	
the	analyte	as	the	sample	passes	by.	There	are	however	studies	having	shown	that	
by	 using	microwells	 containing	 freeze-dried	 detection	 antibodies	 the	 sensitivity	 of	
the	assay	is	further	increased	(Han	et	al.	2016).	The	function	of	the	microwells	is	thus	
to	contain	and	preserve	the	detection	antibody	in	conditions	favorable	for	the	assay,	
obtained	 by	 addition	 of	 buffers	 for	 maintaining	 certain	 pH	 values	 or	 surfactants	
promoting	uniform	movement	of	the	sample	along	the	strip	membrane	(Taranova	et	
al.	2015).	In	addition	to	this	the	microwells	serve	as	the	platform	for	the	assay	itself	
since	the	milk	sample	 is	simply	added	 into	the	them	and	mixed	with	the	detection	
antibody,	followed	by	the	insertion	of	the	test	strip.		
	
The	 nitrocellulose	 (NC)	 membrane	 incorporates	 the	 very	 core	 of	 the	 lateral	 flow	
immunoassay;	the	test	and	control	lines.	The	test	line	consists	of	capture	molecules	
that	 bind	 the	 target	 analyte	 while	 the	 control	 line	 contains	 secondary	 antibodies	
specific	for	the	detection	antibody.	The	control	line	consequently	validates	that	the	
assay	 is	 working	 properly.	 The	 attachment	 of	 the	 capture	 molecules	 to	 the	
membrane	 requires	 instrumentation	 and	 most	 commonly	 positive	 displacement	
systems	are	used.	The	principle	behind	positive	displacement	is	to	directly	dispense	
the	liquid	in	a	line	on	to	the	membrane.	After	the	liquid	dispensing	it	is	essential	that	
the	 membrane	 is	 allowed	 to	 dry	 completely	 to	 ensure	 sufficient	 affixation	 of	 the	
capture	molecules	(Innova	Biosciences	2017).		
	
At	the	end	of	the	lateral	flow	immunoassay	is	the	absorbent	pad.	It	is	necessary	for	
increasing	 the	 sample	 volume	 taken	 up	 by	 the	 test	 strip	 as	 well	 as	 preventing	
backflow	of	the	liquid.	Increased	sample	volume	helps	to	wash	away	any	unattached	
detection	 antibodies	 and	 therefore	 minimizes	 the	 background	 interference,	
improving	the	assay	sensitivity	(Innova	Biosciences	2017).	
	
The	 detection	 antibody	 is	 an	 antibody	 specific	 for	 the	 analyte	 that	 has	 been	
conjugated	 with	 the	 detection	 moiety,	 often	 gold	 nanoparticles	 which	 produce	
colored	readouts.	Monoclonal	antibodies	are	preferred	over	polyclonal	ones	as	they	
can	 be	 produced	 in	 large	 quantities	 while	 maintaining	 high	 specificity	 since	 they	
recognize	a	single	epitope.	The	stability	of	the	detection	antibody	is	a	key	factor	for	
the	assay	since	it	needs	to	maintain	its	characteristics	even	after	having	been	dried	
or	dry-freezed	(Innova	Biosciences	2017).		
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2.	Materials	and	Method	
2.1	Preparation	of	colloidal	gold		
	
The	 colloidal	 gold	 was	 prepared	 using	 the	 Frens	 (Turkevich)	method	 (Wang	 et	 al.	
2014).	 100ml	 of	 0.01%	 (w/v)	 chloroauric	 acid	was	 added	 into	 a	 250ml	 Erlenmeyer	
flask	and	heated	up	to	its	boiling	point,	after	which	2ml	of	1.0%	(w/v)	sodium	citrate	
was	added.	The	yellow	solution	was	allowed	to	boil	while	being	continuously	stirred	
for	approximately	five	minutes,	until	the	color	had	changed	to	red.	The	solution	was	
then	cooled	down	by	continued	stirring	at	room	temperature	and	eventually	stored	
at	 4°C.	 100µlof	 the	 solution	 was	 transferred	 into	 an	 ELISA	 strip	 plate	 microwell	
(JetBIOFIL)	in	order	to	read	off	the	optical	density	at	wavelengths	between	400	and	
800nm.	 The	 newly	 formed	 colloidal	 gold	 was	 then	 examined	 with	 a	 transmission	
electron	microscope.		
	
2.2	Optimization	of	antibody-gold	conjugation		
	
1ml	 of	 colloidal	 gold	 solution	 was	 added	 into	 each	 of	 seven	 different	 Eppendorf	
tubes.	To	find	the	optimal	alkalinity	for	the	conjugation	of	the	gold	nanoparticles	to	
the	 detection	 antibody	 0,	 6,	 8,	 10,	 12,	 14	 and	 16µl	 of	 0.2M	 K2CO3	 (potassium	
carbonate)	was	added	respectively	into	the	Eppendorf	tubes,	followed	by	8µg	of	the	
detection	 antibody	 (monoclonal	 anti-TC,	 mouse	 IgG	 from	 Guangzhou	 Ucando	
Biotechnology,	 6µg/µl).	 The	 Eppendorf	 tubes	were	 left	 to	 incubate	 for	 15	minutes	
and	 then	 100µl	 of	 each	 solution	 was	 transferred	 into	 microwells	 and	 the	 optical	
density	was	read	off	at	a	wavelength	of	530λ	(found	in	step	2.1	to	be	the	wavelength	
at	which	 the	prepared	 colloidal	 gold	 solution	had	 the	highest	optical	 density).	 The	
amount	 of	 added	 K2CO3	that	 resulted	 in	 the	 highest	 optical	 density	 at	 530nm	was	
considered	the	optimal	amount	to	use	(Wang	et	al.	2012).		
	
2.3	Preparation	of	detection	antibody	
	
1ml	 of	 colloidal	 gold	 solution	was	 added	 into	 an	 Eppendorf	 tube,	 followed	 by	 the	
addition	of	8µl	(found	to	be	the	optimal	amount	in	step	2.2)	of	0.2M	K2CO3.	8µg	of	
the	detection	antibody	was	added	and	the	tube	was	left	to	incubate	for	15	minutes	
followed	by	the	addition	of	100µlof	10%	BSA	(see	2.3.1)	and	another	15	minutes	of	
incubation	 time.	 The	 tube	was	 then	 centrifuged	 at	 12000rpm	 for	 15	minutes.	 The	
supernatant	was	removed,	leaving	only	the	pellet	of	antibody	gold	conjugates	at	the	
bottom	which	were	 thereafter	 re-dissolved	 in	 100µl	 of	 redissolution	 solution	 (see	
2.3.2).	This	resulted	in	a	detection	antibody	concentration	of	0.08µg/µl.		
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2.3.1	10%	BSA	
	
50g	of	BSA	(Bovine	Serum	Albumin)	powder	was	weighed	up	and	dissolved	in	500ml	
of	 distilled	 water	 in	 a	 500ml	 Erlenmeyer	 flask.	 The	 solution	 was	 then	 stored	 in	
aliquots	of	50ml	in	-20°C.		
2.3.2	Redissolution	solution	
	
5g	 of	 sucrose,	 2.5g	 of	 mycose	 and	 0.5g	 of	 BSA	 was	 dissolved	 in	 50ml	 of	 distilled	
water,	followed	by	the	addition	of	0.5ml	Tris	buffer	of	pH	8.0.	The	solution	was	then	
stored	in	-20°C.		
	
2.4	Optimization	of	antigen	concentration		
	
The	 antigen	 (TC-BSA	 conjugates	 from	Guangzhou	Ucando	Biotechnology,	 15µg/µl),	
was	 prepared	 in	 small	 PCR-tubes.	 The	 concentrations	 1,	 2,	 3	 and	 4µg/µl	 were	
prepared	by	dilution	with	 10mM	phosphate	buffer	 (see	2.4.1),	 each	 concentration	
being	prepared	in	amounts	of	10µl.	The	different	antigen	concentrations	were	then	
attached	 to	 NC	membranes	 (Unisart	 CN	 140,	 Sartorius)	 to	 form	 test	 lines	 using	 a	
contact	dispenser	(XYZ	dispenser	HM3030,	Kinbio).	The	dispensing	settings	were	set	
to	 a	 rate	 of	 10cm/s	 with	 a	 dispensing	 quantity	 of	 0.8µl	 antigen/cm.	 The	 NC	
membranes	were	 then	dried	at	55°C	 for	15	minutes.	The	 full	 test	 strips	were	 then	
assembled	by	attaching	the	NC	membranes,	absorbent	pads	and	sample	pads	to	the	
supporting	 back	 material	 followed	 by	 cutting	 it	 into	 strips	 using	 Automatic	 Strip	
Cutter	ZQ2000	from	Kinbio.	The	width	of	each	test	strip	was	set	to	0.4	cm.		
	
		 	
	
Figure	 3.	 Showing	 the	 contact	 dispenser	 (left)	 and	 the	 nitrocellulose	 membrane	 with	
recently	attached	antigen	(right).	
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200µl	of	pasteurized,	whole	cow	milk	from	the	brand⾹满楼	was	added	into	each	of	
eight	microwells.	5µl	of	the	detection	antibody	prepared	in	step	2.3	was	then	added	
to	each	microwell	followed	by	mixing	by	pipetting	up	and	down	a	few	times.	The	test	
strips	were	 then	 inserted	 into	 the	microwells,	 two	 of	 each	 antigen	 concentration.	
The	test	strips	were	left	in	the	microwells	for	three	minutes	before	being	taken	out	
and	in	order	to	stop	the	continuation	of	the	process	the	sample	pads	were	removed.	
Pictures	were	taken	to	document	the	resulting	color	 intensity	of	the	test	 lines.	The	
antigen	concentration	that	was	determined	optimal	was	then	used	for	production	of	
more	test	strips	for	further	use	in	following	steps.	
	
2.4.1	Phosphate	buffer	
	
Two	different	solutions	(A	and	B)	were	prepared	separately.	For	solution	A	27,6g	of	
monosodium	 phosphate	 (NaH2PO4H2O)	 was	 dissolved	 in	 1000ml	 of	 deionized	
water.	 Solution	 B	 was	 prepared	 by	 dissolving	 53,6g	 of	 disodium	 phosphate	
(Na2HPO47H2O)	 in	 1000ml	 of	 deionized	 water.	 39ml	 of	 solution	 A	 and	 61ml	 of	
solution	B	were	then	mixed	together	in	a	separate	tube,	forming	a	phosphate	buffer	
stock	solution	of	200mM	and	pH7,	stored	at	4°C.	Before	usage	it	was	further	diluted	
to	10mM.		
	
2.5	Optimization	of	detection	antibody	concentration		
	
Using	the	method	described	in	step	2.3	but	changing	the	amount	of	added	antibody	
to	6,	9,	12	and	15µg,	four	different	detection	antibody	solutions	were	prepared	with	
the	final	concentrations	of	approximately	0.06,	0.00,	0.12	and	0.15µg/µl.		
	
200µl	cow	milk	was	added	into	eight	different	microwells.	Each	detection	antibody	
concentration	 was	 added	 in	 duplicates	 into	 the	 microwells	 in	 amounts	 of	 5µl,	
followed	by	mixing	through	pipetting	up	and	down	a	few	times.	The	test	strips	were	
then	 inserted	 into	 the	 microwells.	 The	 test	 strips	 were	 left	 in	 the	 microwells	 for	
three	minutes	before	being	taken	out	and	 in	order	 to	stop	the	continuation	of	 the	
process	 the	 sample	 pads	 were	 removed.	 Pictures	 were	 taken	 to	 document	 the	
resulting	color	intensity	of	the	test	lines.	
	
2.6	Optimization	of	detection	antibody	volume	
	
200µl	cow	milk	was	added	into	eight	different	microwells.	5,	10,	15	and	20µl	of	the	
detection	 antibody	 solution	 with	 the	 optimal	 concentration	 as	 found	 in	 step	 2.5	
(0.12µg/µl)	 was	 added	 into	 each	 of	 the	 microwells,	 all	 in	 duplicates.	 This	 was	
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followed	by	mixing	through	pipetting	up	and	down	a	few	times.	The	test	strips	were	
then	 inserted	 into	 the	 microwells.	 The	 test	 strips	 were	 left	 in	 the	 microwells	 for	
three	minutes	before	being	taken	out	and	 in	order	 to	stop	the	continuation	of	 the	
process	 the	 sample	 pads	 were	 removed.	 Pictures	 were	 taken	 to	 document	 the	
resulting	color	intensity	of	the	test	lines.	
	
2.7	Optimization	of	pH	in	microwell	
	
200µl	cow	milk	was	added	into	ten	different	microwells.	5µl	of	Tris-HCl	buffer	with	
pH	 values	 7.5,	 8.0,	 8.5	 and	9.0	 respectively	were	 added	 into	 the	microwells,	 all	 in	
duplicates.	 In	 two	 control	microwells	 no	 Tris-HCl	 buffer	was	 added.	 In	 accordance	
with	 the	 optimal	 detection	 antibody	 concentration	 and	 volume	 found	 in	 steps	 2.5	
and	 2.6	 respectively,	 5µl	 of	 0.12µg/µl	 detection	 antibody	 was	 added	 into	 each	
microwell	followed	by	mixing	through	pipetting	up	and	down	a	few	times.	The	test	
strips	 were	 then	 inserted	 into	 the	 microwells.	 The	 test	 strips	 were	 left	 in	 the	
microwells	 for	 three	 minutes	 before	 being	 taken	 out	 and	 in	 order	 to	 stop	 the	
continuation	of	the	process	the	sample	pads	were	removed.	Pictures	were	taken	to	
document	the	resulting	color	intensity	of	the	test	lines.	
2.7.1	Tris-HCl	buffers	of	varying	pH	
	
A	1L	measuring	cylinder	was	filled	with	800ml	of	distilled	water.	121,1g	of	Tris	base	
was	weighed	up	using	a	scale	and	added	to	the	water,	followed	by	the	insertion	of	a	
pH-meter	 and	 addition	 of	 1M	 HCl	 (hydrochloric	 acid)	 until	 the	 desired	 pH	 was	
reached.	Distilled	water	was	then	added	until	the	1L	mark.		
	
2.8	Optimization	of	surfactant	in	microwell		
	
200µl	cow	milk	was	added	into	eight	different	microwells.	5µl	of	Tris-HCl	buffer	with	
pH	7.5	(determined	to	be	the	optimal	pH	in	step	2.7)	was	added	into	each	microwell.	
5,	 10	 and	 15µl	 of	 10%	 (v/v)	 nonionic	 surfactant	 Tween	 20	 (polyoxyethylene	 20	
sorbitan	 monolaurate)	 was	 added	 into	 the	 microwells,	 each	 different	 volume	 in	
duplicates.	 In	 two	control	microwells	no	surfactant	was	added.	 In	accordance	with	
the	optimal	detection	antibody	concentration	and	volume	found	in	steps	2.5	and	2.6	
respectively,	 5µl	 of	 0.12µg/µl	 detection	 antibody	 was	 added	 into	 each	 microwell	
followed	by	mixing	through	pipetting	up	and	down	a	few	times.	The	test	strips	were	
then	 inserted	 into	 the	 microwells.	 The	 test	 strips	 were	 left	 in	 the	 microwells	 for	
three	minutes	before	being	taken	out	and	 in	order	 to	stop	the	continuation	of	 the	
process	 the	 sample	 pads	 were	 removed.	 Pictures	 were	 taken	 to	 document	 the	
resulting	color	intensity	of	the	test	lines.	
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The	 procedure	 was	 repeated	 with	 5%	 (w/v)	 amphoteric	 surfactant	 Tetronic	 1307	
(ethylenediamine	alkoxlate	block	 copolymer)	 and	5%	 (w/v)	 cationic	 surfactant	BAC	
(benzalkonium	chloride)	respectively.			
2.8.1	10%	Tween	20	
	
5g	 of	 Tween	 20	 liquid	 (SIGMA-ALDRICH)	 was	 weighed	 up	 and	 added	 into	 a	 50ml	
Erlenmeyer	flask	followed	by	the	addition	of	distilled	water	until	the	50ml	mark.	The	
solution	was	mixed	and	distributed	into	aliquots	of	1ml,	stored	at	4°C.		
2.8.2	5%	Tetronic	1307	and	BAC	
	
2,5g	 of	 Tetronic	 1307	 powder	 (BASF)	 was	 weighed	 up	 and	 added	 into	 a	 50ml	
Erlenmeyer	flask	followed	by	the	addition	of	distilled	water	until	the	50ml	mark.	The	
solution	was	mixed	and	distributed	unto	aliquots	of	1ml,	stored	at	4°C.		
This	was	repeated	with	BAC	powder	(SIGMA-ALDRICH).		
	
2.9	Determination	of	test	strip	detection	limit		
	
A	 tetracycline	 stock	 solution	with	 concentration	 1000mg/L	 (1000ppm)	was	 bought	
from 中国药品⽣物制品检定所	 (China’s	 National	 Institute	 for	 Food	 and	 Drug	
Control).	This	was	used	to	prepare	1ml	of	tetracycline	diluted	 in	cow	milk	with	the	
concentration	 120ppb.	 400µlof	 the	 120ppb	 tetracycline	 solution	was	 added	 into	 a	
microwell	and	200µl	of	cow	milk	was	added	into	five	different	microwells.		200µl	of	
the	120ppb	solution	was	then	transferred	into	the	first	of	these	microwells	and	the	
content	 carefully	 mixed	 by	 pipetting	 up	 and	 down	 eight	 times.	 The	 process	 of	
transferring	 200µl	 of	 solution	 to	 the	 next	 microwell	 was	 repeated	 until	 the	 last	
microwell,	 in	which	nothing	was	added	and	 the	 remaining	 solution	was	discarded.	
This	 resulted	 in	 six	 microwells	 containing	 200µl	 of	 cow	 milk	 with	 the	 following	
tetracycline	 concentrations:	 120,	 60,	 30,	 15,	 7.5	 and	 0ppb.	 The	 procedure	 was	
repeated	so	that	each	concentration	was	available	in	duplicates.			
	
5µl	 of	 Tris-HCl	 buffer	 with	 pH	 7.5	 (determined	 to	 be	 the	 optimal	 pH	 in	 step	 2.6)	
microwell	 and	 5µl	 of	 Tetronic	 1307	 (determined	 to	 be	 the	 optimal	 surfactant	 and	
volume	in	step	2.8)	was	added	into	the	microwells.	 In	accordance	with	the	optimal	
detection	 antibody	 concentration	 and	 volume	 found	 in	 steps	 2.5	 and	 2.6	
respectively,	 5µl	 of	 0.12µg/µl	 detection	 antibody	 was	 added	 into	 each	 microwell	
followed	by	mixing	through	pipetting	up	and	down	a	few	times.	After	three	minutes	
(to	allow	 the	binding	of	 tetracycline	 to	detection	antibodies	 in	 the	microwells)	 the	
test	strips	were	inserted.	The	test	strips	were	left	in	the	microwells	for	another	three	
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minutes	before	being	taken	out	and	in	order	to	stop	the	continuation	of	the	process	
the	sample	pads	were	removed.	Pictures	were	taken	to	document	the	resulting	color	
intensity	of	the	test	lines.	
	
2.10	Formation	of	control	line		
	
The	secondary	antibody	used	for	the	control	line	was	goat	anti-mouse	IgG	(13mg/ml,	
Berseebio).	10µl	of	the	secondary	antibody	was	prepared	in	a	small	PCR-tube	in	the	
concentration	 0.25µg/µl	 by	 dilution	 with	 10mM	 phosphate	 buffer.	 10µl	 of	 the	
antigen	(TC-BSA	conjugates)	used	for	the	test	line	was	prepared	in	another	PCR-tube	
in	the	concentration	2µg/µl	(chosen	to	be	the	optimal	concentration	in	step	2.4).	The	
two	solutions	were	attached	to	an	NC	membrane,	the	control	line	located	8mm	over	
the	test	line,	and	full	test	strips	were	assembled	according	to	the	method	described	
in	step	2.4.		
	
The	 1000mg/ml	 tetracycline	 stock	 solution	 used	 in	 step	 2.9	 was	 further	 used	 to	
prepare	four	times	1ml	of	cow	milk	containing	tetracycline	in	the	concentrations	0,	
15,	 30	 and	 45ppb.	 200µl	 of	 the	 different	 concentrations,	 each	 in	 duplicates,	were	
added	 into	microwells.	 This	was	 followed	by	 the	addition	of	5µl	of	pH	7.5	Tris-HCl	
buffer,	5µl	of	5%	Tetronic	1307	and	5µl	of	the	detection	antibody	with	concentration	
12µg/µl,	 all	 according	 to	 previously	 determined	 optimal	 conditions.	 After	 three	
minutes	 the	newly	produced	 test	 strips	were	 inserted	 into	 the	microwells	 and	 left	
there	 for	 another	 three	minutes	 before	 being	 taken	 out	 and	 in	 order	 to	 stop	 the	
continuation	of	the	process	the	sample	pads	were	removed.	Pictures	were	taken	to	
document	the	resulting	color	intensity	of	the	test-	and	control	lines.	
	
This	process	was	then	repeated	for	two	additional	concentrations	of	the	secondary	
antibody:	 0.15µg/µl	 and	 0.08µg/µl.	 The	 optimal	 concentration	 of	 the	 secondary	
antibody	was	then	used	for	large-scale	production	of	test	strips.		
	
2.11	Freeze-drying	of	microwell	content	
	
For	the	freeze-drying	each	microwell	was	to	contain	a	total	amount	of	100µl	liquid,	
consisting	 of	 5µl	 pH	 7.5	 Tris-HCl	 buffer,	 5µl	 5%	 Tetronic	 1307,	 5µl	 of	 detection	
antibody	with	the	concentration	12µg/µl,	50µl	stabilizing	buffer	and	24,5µl	distilled	
water.	 This	 was	 prepared	 for	 large-scale	 production	 by	 multiplying	 every	 amount	
with	 700,	 resulting	 in	 24.5ml	 distilled	water,	 35ml	 stabilizing	 buffer,	 3.5ml	 pH	 7.5	
Tris-HCl	 buffer,	 3.5ml	 5%	 Tetronic	 1307	 and	 3.5ml	 of	 detection	 antibody	with	 the	
concentration	12µg/µl	 being	 added	 into	 a	 100ml	 Erlenmeyer	 flask.	 672	microwells	
were	then	filled	with	100µl	of	the	liquid	and	put	into	a	freeze-dryer	(EPSILON	2-8D,	
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Christ)	for	freeze	drying	following	a	specific	cycle	developed	by	the	lab.	The	finished	
product	was	 then	packed	together	with	produced	test	 strips	 in	plastic	bottles	with	
desiccant	 caps	 for	 protection	 against	moisture.	 Each	 plastic	 bottle	 was	 filled	 with	
eight	microwells	and	eight	test	strips.	
	
	
Figure	4.	Showing	the	microwells	right	before	the	freeze-drying	process.			
	
2.12	Accelerated	stability	testing		
	
Four	desiccant	bottles	containing	the	finished	product	(eight	sets	of	microwells	and	
test	strips)	were	put	into	an	incubator	at	60°C.	The	bottles	were	then	taken	out	after	
3,	6,	9	and	12	days	respectively.	The	1000mg/ml	tetracycline	stock	solution	used	in	
step	 2.9	 was	 further	 used	 to	 prepare	 cow	 milk	 containing	 tetracycline	 in	 the	
concentrations	0,	15,	30	and	45ppb.	200µl	of	 the	different	concentrations,	each	 in	
duplicates,	were	added	 into	microwells	 followed	by	 careful	mixing	by	pipetting	up	
and	down.	After	three	minutes	the	test	strips	were	inserted	into	the	microwells	and	
left	there	for	another	three	minutes	before	being	taken	out	and	in	order	to	stop	the	
continuation	of	the	process	the	sample	pads	were	removed.	Pictures	were	taken	to	
document	the	resulting	color	 intensity	of	the	test-	and	control	 lines	in	order	to	see	
whether	 the	assay	was	still	 reliable.	Every	1	day	at	60°C	with	 remained	stability	of	
the	 assay	 corresponds	 to	 1	 month	 of	 shelf	 life	 under	 normal	 storage	 conditions	
(room	temperature)	according	to	previous	studies	(Gong	et	al.	2012).		
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3.	Results	
	
3.1	Characterization	of	colloidal	gold	and	antibody-gold	conjugation		
	
The	 produced	 gold	 nanoparticles	 were	 examined	 using	 a	 transmission	 electron	
microscope	(see	figure	5)	and	it	can	be	seen	that	the	particles	were	relatively	well-
dispersed	and	of	slightly	varying	size	and	shape,	with	a	mean	diameter	of	around	25-
30nm.		
	
	
Figure	5.	Showing	a	fraction	of	the	gold	nanoparticles	present	in	the	colloidal	gold	solution	
as	viewed	with	a	transmission	electron	microscope.	
	
An	optical	density	spectrum	of	the	colloidal	gold	between	wavelengths	400nm	and	
800nm	was	 obtained	 using	 a	 spectrophotometer,	 as	 can	 be	 seen	 in	 figure	 6.	 The	
peak	was	found	at	530nm.		
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Figure	6.	Showing	the	optical	density	at	different	wavelengths	for	the	colloidal	gold.	The	
optical	density	was	found	to	peak	at	530nm.	
This	 was	 used	 for	 the	 determination	 of	 the	 optimal	 amount	 of	 added	 K2CO3	 for	
antibody-gold	 conjugation,	 where	 the	 amount	 that	 generated	 the	 highest	 optical	
density	at	a	wavelength	of	530nm	was	found	to	be	8µl	(figure	7).		
	
	
Figure	7.	Showing	the	optical	density	of	the	antibody-gold	conjugate	solution	at	530nm	for	
different	amounts	of	added	K2CO3.	The	highest	optical	density	was	obtained	when	8µl	of	
K2CO3	was	added.	
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3.2	Optimal	antigen	concentration		
	
Figure	 8	 shows	 the	 resulting	 color	 intensities	 of	 test	 lines	 containing	 different	
concentrations	 of	 the	 antigen.	 The	 intensity	 reached	 a	 peak	 at	2µg/µl,	which	was	
also	 chosen	 as	 the	 optimal	 concentration	 since	 higher	 color	 intensities	 of	 the	 test	
lines	for	negative	samples	increases	the	sensitivity	of	the	assay.		
	
	
	
Figure	8.	 Showing	 the	 resulting	 test	 line	 intensity	after	altering	 the	 concentration	of	 the	
antigen	(TC-BSA).	In	duplicates	from	the	left:	1,	2,	3	and	4µg/µl.	The	highest	color	intensity	
was	obtained	at	a	concentration	of	2µg/µl	(see	blue	arrow),	which	was	determined	to	be	
the	optimal	one.	5µl	of	detection	antibody	with	concentration	0.08µg/µl	was	used.		
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3.3	Optimal	detection	antibody	concentration	
	
Figure	9	shows	the	resulting	color	intensities	of	the	test	lines	after	addition	of	5µl	of	
different	detection	antibody	concentrations.	The	 intensity	seemed	to	 increase	with	
increasing	concentration,	but	with	a	barely	detectable	difference	between	the	two	
highest	concentrations,	0.12	and	0.15µg/µl.	Therefore	0.12µg/µl	was	chosen	as	the	
optimal	one,	as	less	usage	of	antibody	is	preferable	from	an	economical	aspect.		
	
	
Figure	 9.	 Showing	 the	 resulting	 test	 line	 intensity	 after	 addition	 of	 5µl	 of	 detection	
antibody	 of	 different	 concentrations.	 From	 the	 left	 in	 duplicates:	 0.06,	 0.09,	 0.12	 and	
0.15µg/µl.	 The	 optimal	 concentration	 was	 chosen	 to	 be	 0.12µg/µl	 (see	 blue	 arrow).	
Antigen	concentration	in	test	line	was	2µg/µl.		
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3.4	Optimal	detection	antibody	volume	
	
Figure	10	shows	the	resulting	color	intensities	of	test	lines	after	addition	of	different	
volumes	 of	 detection	 antibody	 with	 the	 concentration	 0.12µg/µl.	 The	 intensity	
seemed	 to	 increase	 with	 an	 increased	 volume	 of	 added	 detection	 antibody,	 but	
increased	 volume	 also	 resulted	 in	 red	 staining	 of	 the	 test	 strip	 background.	 To	
maintain	a	clean	look	for	the	test	strip	the	volume	5µl	was	determined	optimal.		
	
	 	
Figure	10.	Showing	the	resulting	test	 line	 intensity	after	addition	of	different	volumes	of	
detection	antibody	with	the	concentration	0.12µg/µl.	From	the	left	in	duplicates:	5,	10,	15	
and	 20ul.	 The	 optimal	 volume	 was	 determined	 to	 be	 5µl	 (see	 blue	 arrow).	 Antigen	
concentration	in	test	line	was	2µg/µl.	
	
	
	
	
	
	
	
	 20	
3.5	Optimal	pH	in	microwell		
	
Figure	11	 shows	 the	 resulting	 color	 intensities	of	 test	 lines	after	addition	of	5µl	of	
Tris-HCl	buffers	with	different	pH	values.	Higher	pH	values	decreased	the	intensity	of	
the	 test	 line.	 5µl	 of	 Tris-HCl	 buffer	 with	 pH	 7.5	 was	 chosen	 to	 be	 the	 optimal	
alternative.		
	
	
Figure	11.	Showing	the	resulting	test	line	intensities	after	addition	of	5µl	of	Tris-HCl	buffers	
with	 different	 pH	 values.	 From	 the	 left	 in	 duplicates:	 Controls,	 pH7.5,	 pH8.0,	 pH8.5	 and	
pH9.0.	 The	 highest	 color	 intensity	 was	 obtained	 at	 pH7.5	 (see	 blue	 arrow),	 which	 was	
determined	to	be	the	optimal	one.	5µl	of	detection	antibody	with	concentration	0.12µg/µl	
was	used	and	antigen	concentration	in	test	line	was	2µg/µl.	
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3.6	Optimal	surfactant	in	microwell	
	
Figure	12	shows	the	resulting	color	intensities	of	test	lines	after	addition	of	different	
volumes	 of	 the	 nonionic	 surfactant	 10%	 Tween	 20.	 Addition	 of	 Tween	 20	 had	 a	
negative	effect	on	the	color	intensity	and	was	so	deemed	unsuitable	for	usage	in	the	
assay.	
	
	
Figure	12.	Showing	the	resulting	test	line	intensities	after	the	addition	of	different	volumes	
of	10%	Tween	20.	From	the	left	in	duplicates:	Controls,	5,	10	and	15ul.	5µl	of	Tris-HCl	pH	
7.5,	5µl	of	detection	antibody	with	concentration	0.12µg/µl	and	antigen	concentration	in	
test	line	of		2µg/µl	was	used.	
	
Figure	13	shows	the	resulting	change	in	milk	texture	after	addition	of	5µl	of	cationic	
surfactant	5%	BAC.	After	removal	of	the	milk	from	the	microwells	there	was	a	clear	
difference	 between	 the	 control	 and	 the	 one	 containing	 BAC.	Milk	 containing	 BAC	
formed	lumps	and	stuck	to	the	walls	of	the	microwell.	BAC	was	thus	determined	not	
to	be	suitable	for	usage	in	the	assay.		
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Figure	 13.	 Showing	 the	 change	 in	 milk	 texture	 after	 the	 addition	 of	 5µl	 of	 BAC.	 After	
removal	 of	 the	milk	 it	 was	 seen	 that	 the	 one	 containing	 only	milk	 (left	microwell)	 had	
clean	walls	while	 the	one	also	 containing	BAC	 (right	microwell)	 had	milk	 lumps	 stuck	 to	
the	walls.		
Figure	14	shows	the	resulting	color	intensities	of	test	lines	after	addition	of	different	
volumes	 of	 the	 amphoteric	 surfactant	 5%	 Tetronic	 1307.	 There	 was	 no	 visible	
difference	 in	 intensity	 between	 the	 controls	 and	 the	 samples	 containing	 5µl	 of	
Tetronic	1307.	The	samples	containing	10	and	15µl	 respectively	 resulted	 in	 slightly	
decreased	 color	 intensities.	Using	5µl	 of	 Tetronic	 1307	was	 determined	 to	 be	 the	
optimal	 option	 as	 it	 did	 not	 have	 a	 negative	 effect	 on	 the	 color	 intensity	 and	 the	
presence	 of	 surfactant	 in	 the	 microwell	 has	 been	 documented	 to	 have	 positive	
effects	on	lateral	flow	immunoassays.		
	
	
Figure	14.	Showing	the	resulting	test	line	intensities	after	the	addition	of	different	volumes	
of	5%	Tetronic	1307.	From	the	left	in	duplicates:	0,	5,	10	and	15ul.	5µl	of	5%	Tetronic	1307	
was	determined	to	be	the	optimal	volume	(see	blue	arrow).	5µl	of	Tris-HCl	pH	7.5,	5µl	of	
detection	antibody	with	concentration	0.12µg/µl	and	antigen	concentration	in	test	line	of	
2µg/µl	was	used.	
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3.7	Test	strip	detection	limit	
	
The	 test	 strips	 and	 the	 optimized	 microwell	 conditions	 from	 previous	 steps	 were	
used	on	cow	milk	containing	concentrations	of	tetracycline	between	0	and	120ppb	in	
order	 to	 find	a	 suitable	detection	 limit	of	 the	developed	assay.	 It	was	 intended	 to	
find	 the	 concentration	 where	 the	 resulting	 color	 intensity	 of	 the	 test	 line	 was	
somewhere	 in	between	a	 clearly	positive	or	negative	 result,	meaning	a	detectable	
line	 but	 not	 with	 the	 same	 color	 intensity	 produced	 by	 a	 completely	 negative	
sample.	In	figure	15	it	can	be	seen	that	at	a	concentration	of	30ppb	visible	but	weak	
lines	appeared,	and	so	30ppb	was	chosen	to	be	the	detection	limit.		
	
		
Figure	 15.	 Showing	 the	 resulting	 test	 line	 intensities	 after	 testing	 cow	 milk	 containing	
different	 concentrations	 of	 tetracycline.	 From	 the	 left	 in	 duplicates:	 120,	 60,	 30,	 15,	 7.5	
and	0ppb.	At	30ppb	a	visible	but	weak	line	appeared	and	that	concentration	was	chosen	
as	the	detection	limit	(see	blue	arrow).	5µl	of	5%	Tetronic	1307,	5µl	of	Tris-HCl	pH	7.5,	5µl	
of	detection	antibody	with	concentration	0.12µg/µl	and	antigen	concentration	in	test	line	
of	2µg/µl	was	used.	
	
3.8	Control	line		
	
The	 aim	 of	 the	 formation	 of	 the	 control	 line	 was	 to	 find	 a	 concentration	 of	 the	
secondary	antibody	that	would	result	in	an	equal	color	intensity	as	the	test	line	in	a	
sample	 with	 a	 tetracycline	 concentration	 of	 30ppb	 (the	 detection	 limit).	 Like	 this	
comparison	of	the	intensity	of	the	test	line	relative	to	the	control	line	would	enable	
concluding	whether	the	sample	contains	more	or	less	than	30ppb	of	tetracycline.		
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Figure	16	shows	the	resulting	test-	and	control	 line	 intensities	at	concentrations	of	
tetracycline	 ranging	 from	0	 to	45ppb	when	a	 secondary	antibody	 concentration	of	
0.25µg/µl	 was	 used.	 It	 can	 be	 seen	 that	 from	 the	 sample	 containing	 30ppb	
tetracycline	the	intensity	of	the	control	line	was	higher	than	that	of	the	test	line.	This	
indicates	that	the	concentration	of	the	secondary	antibody	is	too	high	and	thus	not	
suitable	for	test	strips	with	a	desired	detection	limit	of	30ppb.			
	
		 		
Figure	16.	Showing	the	resulting	test-	and	control	line	intensities	in	samples	with	different	
concentrations	of	tetracycline	when	a	secondary	antibody	concentration	of	0.25µg/µl	was	
used.	From	the	left	in	duplicates:	0,	15,	30	and	45ppb.	At	30ppb	the	intensity	of	the	control	
line	was	higher	than	that	of	the	test	line	(see	yellow	arrow).	5µl	of	5%	Tetronic	1307,	5µl	
of	 Tris-HCl	 pH	 7.5,	 5µl	 of	 detection	 antibody	 with	 concentration	 0.12µg/µl	 and	 antigen	
concentration	in	test	line	of	2µg/µl	was	used.	
		
Figure	17	shows	the	resulting	test-	and	control	 line	 intensities	at	concentrations	of	
tetracycline	 ranging	 from	0	 to	45ppb	when	a	 secondary	antibody	 concentration	of	
0.15µg/µl	 was	 used.	 It	 can	 be	 seen	 that	 from	 the	 sample	 containing	 30ppb	
tetracycline	the	intensity	of	the	control	line	was	higher	than	that	of	the	test	line.	This	
indicates	that	the	concentration	of	the	secondary	antibody	is	still	too	high	and	thus	
not	suitable	for	test	strips	with	a	desired	detection	limit	of	30ppb.			
	
ßControl	line	
ßTest	line		
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Figure	17.	Showing	the	resulting	test-	and	control	line	intensities	in	samples	with	different	
concentrations	of	tetracycline	when	a	secondary	antibody	concentration	of	0.15µg/µl	was	
used.	From	the	left	in	duplicates:	0,	15,	30	and	45ppb.	At	30ppb	the	intensity	of	the	control	
line	was	higher	than	that	of	the	test	line	(see	yellow	arrow).	5µl	of	5%	Tetronic	1307,	5µl	
of	 Tris-HCl	 pH	 7.5,	 5µl	 of	 detection	 antibody	 with	 concentration	 0.12µg/µl	 and	 antigen	
concentration	in	test	line	of	2µg/µl	was	used.	
	
	
Figure	18	shows	the	resulting	test-	and	control	 line	 intensities	at	concentrations	of	
tetracycline	 ranging	 from	0	 to	45ppb	when	a	 secondary	antibody	 concentration	of	
0.08µg/µl	 was	 used.	 It	 can	 be	 seen	 that	 from	 the	 sample	 containing	 30ppb	
tetracycline	the	intensity	of	the	control	line	was	highly	similar	to	that	of	the	test	line.	
This	 indicates	 that	a	 secondary	antibody	 concentration	of	0.08µg/µl	 is	 suitable	 for	
test	strips	with	a	desired	detection	limit	of	30ppb.			
	
ßControl	line	
ßTest	line		
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Figure	18.	Showing	the	resulting	test-	and	control	line	intensities	in	samples	with	different	
concentrations	of	tetracycline	when	a	secondary	antibody	concentration	of	0.08µg/µl	was	
used.	From	the	left	in	duplicates:	0,	15,	30	and	45ppb.	At	30ppb	the	intensity	of	the	control	
line	was	equal	to	that	of	the	test	line	(see	blue	arrow).	5µl	of	5%	Tetronic	1307,	5µl	of	Tris-
HCl	 pH	 7.5,	 5µl	 of	 detection	 antibody	 with	 concentration	 0.12µg/µl	 and	 antigen	
concentration	in	test	line	of	2µg/µl	was	used.	
	
	
Figure	 19	 shows	 an	 adapted	 version	 of	 the	 Shenzhen	 Bioeasy	 Biotechnologies	 Co.	
Instruction	manual	 for	 the	use	of	 their	melamine	test	strip.	The	principle	 is	exactly	
the	same	for	the	developed	tetracycline	test	strip.	If	no	color	is	visible	on	the	control	
line	the	assay	is	considered	invalid.	 If	the	test	 line	has	a	higher	color	 intensity	than	
the	 control	 line	 the	 sample	 is	 considered	 negative	 (<30ppb	 tetracycline).	 If	 the	
control	line	and	the	test	line	has	the	same	color	intensity	the	sample	would	contain	
approximately	30ppb	tetracycline.	 If	 the	test	 line	has	a	weaker	color	 intensity	than	
the	control	 line	the	sample	is	considered	positive	(>30ppb	tetracycline).	Comparing	
figure	 18	 with	 this	 manual	 shows	 that	 the	 developed	 assay	 complies	 with	 these	
guidelines.		
	
ßControl	line	
ßTest	line	
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Figure	19.	 Showing	 the	 instructions	 for	 interpretation	of	 the	 test	 strips	 as	 adapted	 from	
the	Shenzhen	Bioeasy	Biotechnologies	Co.	Manual	for	use	of	their	melamine	test	strip.	 If	
no	color	is	visible	on	the	control	line	the	assay	is	considered	invalid.	If	the	test	line	has	a	
higher	color	 intensity	 than	the	control	 line	the	sample	 is	considered	negative	 (under	 the	
detection	 limit).	 If	 the	 control	 line	 and	 the	 test	 line	 has	 the	 same	 color	 intensity	 the	
sample	would	 contain	 a	 concentration	 of	 the	 analyte	 around	 the	 detection	 limit	 of	 the	
assay.	 If	 the	 test	 line	 has	 a	 weaker	 color	 intensity	 than	 the	 control	 line	 the	 sample	 is	
considered	positive	(over	the	detection	limit).	
	
3.9	Finished	product	
	
Figure	 20	 shows	 the	 appearance	 of	 the	 finished	 product.	 Desiccant	 bottles	 were	
filled	 with	 sets	 of	 eight	 microwells	 and	 test	 strips	 used	 together	 for	 detection	 of	
tetracycline	in	cow	milk.	Users	of	the	product	only	need	to	add	200µl	of	milk	samples	
into	 the	 microwell	 and	 mix	 carefully	 with	 a	 pipette	 followed	 by	 waiting	 three	
minutes	before	 inserting	a	test	strip	and	then	another	three	minutes	before	taking	
the	 strip	 out.	 Comparisons	with	 an	 instruction	manual	 such	 as	 the	 one	 showed	 in	
figure	 19	 then	 allows	 for	 determination	 of	 whether	 the	 sample	 is	 positive	 or	
negative.		
	
	 28	
	
Figure	20.	Showing	the	finished	product	and	its	distribution.	Each	plastic	desiccant	bottle	
(left)	containing	a	set	of	eight	covered	microwells	with	freeze-dried	components	and	eight	
test	strips	(right).	
	
3.10	Accelerated	stability	testing	
	
Figure	21	shows	the	resulting	test-	and	control	 line	 intensities	for	the	batch	of	test	
strips	 and	microwells	 that	 had	 been	 stored	 at	 60°C	 for	 12	 days.	 For	 the	 samples	
containing	0	and	15ppm	 (negative)	 the	 test	 lines	had	a	higher	 color	 intensity	 than	
the	 control	 lines,	 at	 the	 detection	 limit	 (30	 ppb)	 the	 intensities	 of	 the	 test-	 and	
control	 line	 was	 similar	 and	 at	 45ppb	 (positive)	 the	 intensity	 of	 the	 test	 line	 was	
weaker	than	that	of	the	control	 line,	all	 in	accordance	with	the	desired	principal	of	
the	 assay	 (see	 figure	 19).	 Conversion	 of	 stability	 for	 12	 days	 at	 60°	 into	 normal	
storage	conditions	indicates	that	the	developed	assay	should	have	an	expected	shelf	
life	of	at	least	12	months.		
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Figure	21.	Showing	the	results	from	the	12th	and	final	day	of	the	accelerated	stability	test.	
The	test-	and	control	line	intensities	in	samples	with	different	concentrations	of	
tetracycline	can	be	seen.	From	the	left	in	duplicates:	0,	15,	30	and	45ppb.		
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4.	Discussion	
	
The	aim	of	this	project	was	to	develop	and	optimize	a	commercially	utilizable	micro-
well	based	 lateral	 flow	 immunoassay	 for	 the	detection	of	 tetracycline	 in	 cow	milk.	
The	 optimized	 conditions	 leading	 to	 the	 final	 product	 are	 summarized	 as	 follows:	
Each	test	strip	included	a	test	line	with	an	antigen	(TC-BSA)	concentration	of	2µg/µl	
and	a	control	 line	with	a	secondary	antibody	 (goat	anti-mouse	 IgG)	concentration	
of	0.08µg/µl.	Each	microwell	contained	5µl	of	detection	antibody	 (anti-TC)	with	a	
concentration	of	0.12µg/µl	as	well	as	5µl	of	Tris-HCl	buffer	with	pH	7.5	and	5µl	of	
the	surfactant	Tetronic	1307.	These	conditions	resulted	in	an	assay	detection	 limit	
of	 30ppb	 tetracycline	and	an	expected	shelf	 life	 of	 at	 least	 12	months.	 The	assay	
time	is	around	6-7	minutes.	
	
The	characteristics	of	 the	developed	assay	are	of	comparable	standards	with	other	
lateral	 flow	immunoassays.	For	example,	the	fully	commercialized	Charm	ROSA	Tet	
test	is	developed	by	Charm	Sciences,	Inc.	and	detects	tetracycline	in	milk.	The	assay	
time	is	8	minutes	and	the	detection	limit	is	100ppb	for	tetracycline	(Charm	Sciences	
2017).	 Comparing	 with	 the	 developed	 assay	 the	 assay	 times	 are	 very	 similar	 but	
there	is	a	significant	difference	in	the	sensitivity.	The	Charm	ROSA	Tet	test	is	suitable	
for	 the	 European	 market	 since	 the	 MRL	 requirements	 for	 tetracycline	 residues	 is	
100ppb.	The	developed	assay	could	also	be	used	in	the	European	market	but	might	
be	considered	to	be	unnecessarily	sensitive,	leading	to	milk	being	labeled	as	positive	
for	 tetracycline	and	so	rejected	despite	containing	 less	 tetracycline	than	the	actual	
MRL.	The	Charm	ROSA	Tet	test	is	on	the	other	hand	too	insensitive	for	the	Chinese	
market	where	the	MRL	is	50ppb.	A	detection	limit	of	30ppb,	which	is	the	case	for	the	
developed	 assay,	works	well	 for	 the	 Chinese	market	 since	 it	 can	 be	 considered	 to	
have	a	reasonable	safety	margin.		
	
The	developed	assay	does	not	require	the	use	and	preparation	of	a	conjugate	pad,	
which	significantly	reduces	the	complexity	of	test	strip	assembling.	Using	a	conjugate	
pad	also	implies	the	need	for	the	sample	to	flow	through	more	layers,	increasing	the	
risk	 for	 loss	 of	 detection	 antibody	 or	 clogging	 of	 samples	 during	 transportation	
through	the	strip,	affecting	the	sensitivity.	The	layer	on	layer	strip	that	the	conjugate	
pad	also	 causes	entails	 the	usage	of	 a	plastic	housing	 to	 keep	everything	 in	place,	
which	 increases	the	material	costs	 (Kabri	et	al.	2010).	The	developed	assay	 instead	
uses	a	microwell	containing	 the	detection	antibody,	making	 the	preparation	of	 the	
assay	more	straight-forward,	while	not	compromising	the	sensitivity.		
	
Since	 the	 colloidal	 gold	 is	 directly	 correlated	 with	 the	 sensitivity	 of	 the	 assay	 the	
production	 step	 is	 of	 very	 high	 importance.	 In	 figure	 5	 the	 resulting	 gold	
nanoparticles	can	be	seen	and	the	sizes	and	shapes	of	the	individual	particles	differ	
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to	a	certain	extent	from	each	other.	In	this	aspect	there	is	room	for	improvement	for	
the	assay	since	gold	nanoparticles	of	different	sizes	move	through	the	test	strips	at	
different	 speeds,	 resulting	 in	 differing	 sensitivities	 from	 assay	 to	 assay.	 (Innova	
Biosciences	2017).		
	
During	the	development	process	three	different	kinds	of	surfactants	were	added	to	
the	microwells	to	investigate	which	had	the	best	effect	on	the	assay.	Addition	of	the	
cationic	 surfactant	 benzalkonium	 chloride	 seemed	 to	 cause	 lump	 formation	 in	 the	
milk	 sample	 (see	 figure	 13).	 Addition	 of	 non-ionic	 surfactant	 Tween	 20	 and	
amphoteric	 surfactant	 Triton	 1307,	 both	 non-ionic	 surfactants,	 did	 not	 have	 that	
effect	on	the	milk.	Milk	proteins	such	as	casein	are	normally	negatively	charged	and	
are	present	as	colloidal	solutions	(Tetra	Pak	2017).	It	is	possible	that	by	addition	of	a	
cationic	 surfactant	 the	 colloidal	 solution	 is	 destabilized	 and	 starts	 to	 coagulate	
because	 the	 proteins	 lose	 their	 charge	 and	 stop	 repelling	 each	 other,	 causing	 the	
milk	 lumps.	 It	 is	 therefore	 concluded	 that	 cationic	 surfactants	 are	 not	 suitable	 for	
this	kind	of	milk-directed	assay.		
	
The	developed	assay	 lacks	some	necessary	steps	 in	order	to	be	fully	acknowledged	
commercially.	The	test	strip	is	stated	to	have	a	detection	limit	at	30ppb	tetracycline	
but	 in	 order	 to	 verify	 its	 accuracy	 the	 results	 from	 the	 assay	 for	 several	 different	
kinds	 of	milk	 samples	 should	 be	 compared	with	 those	 from	 a	more	 sophisticated	
method	such	as	liquid	chromatography-mass	spectrometry	(LC-MS)	that	can	provide	
exact	 concentration	 figures	 (Han	 et	 al.	 2016).	 This	 step	 is	 of	 great	 importance	 to	
confirm	the	reliability	of	the	test	strip.		
	
Another	aspect	that	needs	to	be	considered	is	that	of	cross-reactivity.	It	is	not	known	
if	 structures	 closely	 related	 to	 tetracycline	 might	 interfere	 or	 be	 detected	 in	 the	
assay.	This	weakness	could	be	prevented	by	testing	for	cross-reactivity,	 in	this	case	
by	adding	the	known	tetracycline	analogues	chlortetracycline	and	oxytetracycline	to	
milk	samples	and	seeing	whether	cross-reactivity	occurs.	 If	 that	should	be	the	case	
the	assay	cannot	be	used	for	tetracycline	specifically	but	could	instead	be	used	as	a	
screening	 test	 for	antibiotics	of	 the	 tetracycline	 family	 in	general.	Should	a	 sample	
show	positive	results	it	could	be	sent	to	a	lab	for	further	testing	using	LC-MS	which	
would	provide	the	exact	identity	and	concentration	of	the	contaminant.		
	
4.1	Future	work	
	
In	cases	where	a	farmer	or	veterinary	wants	to	check	residues	in	milk	from	a	specific	
cow	 known	 to	 have	 been	 given	 a	 certain	 kind	 of	 antibiotic	 the	 kind	 of	 assay	
developed	 works	 well.	 There	 are	 however	 situations	 where	 the	 milk	 is	 to	 be	
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screened	 for	 a	 lot	 of	 different	 kinds	 of	 antibiotics,	 for	 example	 in	 milk	 analyzing	
laboratories,	where	no	previous	knowledge	about	what	the	cattle	has	been	given	is	
at	 hand.	 In	 those	 cases	 it	 would	 be	 more	 efficient	 to	 use	 test	 strips	 capable	 of	
screening	 for	 several	 antibiotics	 simultaneously.	 A	 market	 would	 therefore	 be	
available	 for	multiplex	assays,	 in	other	words	 test	 strips	with	 several	different	 test	
lines.	 This	 requires	 assays	 of	 a	 different	 approach	 since	 the	 different	 antibiotics	
would	most	likely	have	different	detection	limits.	
	
The	 developed	 test	 strip	 is	 read	 off	 visually	 and	 is	 therefore	 appropriate	 for	
qualitative	measurements,	requiring	positive	samples	to	be	sent	to	 laboratories	for	
more	extensive	testing	 in	order	to	obtain	more	exact	results.	More	effort	could	be	
put	 into	 making	 it	 a	 more	 quantitative	 assay	 by	 employing	 colorimetric	
measurements	that	convert	test	line	intensities	into	approximate	concentrations.		
	
Since	 the	 lateral	 flow	 immunoassays	 have	 a	 commercial	 purpose	 the	 economical	
aspect	 is	 of	 constant	 consideration.	 More	 work	 could	 be	 put	 into	 cutting	 the	
production	 costs	 and	 one	 of	 the	 major	 expenses	 is	 antibodies	 used	 in	 the	 assay.	
Instead	of	using	passive	adsorption	methods	to	create	the	antibody-gold	conjugates	
slightly	more	 complex	 covalent	 conjugation	 should	 be	 further	 looked	 into	 since	 it	
uses	significantly	less	of	the	antibody	(Innova	Biosciences	2017).		
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